Companies: 10,795·Total market cap: $144.5T
Barinthus Biotherapeutics plc

Barinthus Biotherapeutics plc

BRNSNASDAQHealthcare● Active
$0.74
+$0.02(+2.49%)
Market Cap$30142398
P/E Ratio—
52W High$2.92
52W Low$0.512
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Barinthus Biotherapeutics plc (BRNS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001828185 · BRNS · NASDAQ · as of Jun 10, 2026

Filing snapshot

247
Total Filings
8-K
Latest Form
2026-05-21
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001828185 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-13
Fiscal Year End
Mar 13, 2026
Accession No.
0001828185-26-000012
Primary Document
brns-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001828185 · Accession 0001828185-26-000012

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
FORM 8-K
2026-05-21Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2026-05-21
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-05-01
View
10-QQuarterly Report
10-Q
2026-04-30
View
8-KCurrent Report
8-K
2026-04-30
View
DEFM14ADEFM14A
DEFM14A
2026-04-30
View
8-KCurrent Report
FORM 8-K
2026-04-22
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-04-13
View
8-KCurrent Report
FORM 8-K
2026-03-31
View
10-KAnnual Report
10-K
2026-03-13
View
8-KCurrent Report
8-K
2026-03-13
View
425425
425
2026-02-23
View
8-KCurrent Report
FORM 8-K
2026-02-23
View
8-KCurrent Report
8-K
2026-01-06
View
8-KCurrent Report
8-K
2025-12-10
View
10-QQuarterly Report
10-Q
2025-11-07
View
Showing 1–15 of 167 filingsForm 4 / 144 hidden· 247 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001828185  |  Exchange: NASDAQ · Healthcare

Barinthus Biotherapeutics plc (NASDAQ: BRNS) has submitted 247 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001828185, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Barinthus Biotherapeutics plc's most comprehensive regulatory disclosure. The most recent Barinthus Biotherapeutics plc 10-K was filed on 2026-03-13 for fiscal year ending 2026. Historical BRNS 10-K annual reports are available from 2020 through 2026.

Investors researching Barinthus Biotherapeutics plc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
KPTI SEC Filings →MRSN SEC Filings →OKUR SEC Filings →KZR SEC Filings →INMB SEC Filings →ALGS SEC Filings →SNTI SEC Filings →CVM SEC Filings →
→ BRNS Financials→ BRNS Earnings→ BRNS Insider Trades

Frequently Asked Questions

BRNS SEC Filings · 8 questions

Barinthus Biotherapeutics plc (BRNS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 247 filings and access original documents at no cost. Barinthus Biotherapeutics plc's CIK is 0001828185.

BRNS SEC filingsBarinthus Biotherapeutics plc SEC documentsfind BRNS 10-K